Immunotherapy with STING and TLR9 agonists promotes synergistic therapeutic efficacy with suppressed cancer-associated fibroblasts in colon carcinoma

The innate immune sensing of nucleic acids using effective immunoadjuvants is critical for increasing protective immune responses against cancer. Stimulators of interferon genes (STING) and toll-like receptor 9 (TLR9) agonists are considered promising candidates in several preclinical tumor models w...

Descripción completa

Detalles Bibliográficos
Autores principales: Hajiabadi, Sare, Alidadi, Soodeh, Montakhab Farahi, Zohreh, Ghahramani Seno, Mohammad M., Farzin, Hamidreza, Haghparast, Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611477/
https://www.ncbi.nlm.nih.gov/pubmed/37901237
http://dx.doi.org/10.3389/fimmu.2023.1258691

Ejemplares similares

Ejemplares similares